T he intestinal mucosa is the largest interface between the host and its environment. It forms a barrier limiting the entrance of the luminal commensal bacteria and pathogens. 1 This barrier is not fully impermeable but allows the passage of small amounts of molecules from the intestinal lumen to the internal milieu. [1] [2] [3] This function is mediated by epithelial cells and the gut-associated lymphoid tissue which is organized in isolated lymphoid follicles and Peyer's patches (PPs). 2 An impaired intestinal epithelial tight junction (TJ) barrier function has been shown to play a key role in the pathogenic mechanisms leading to intestinal inflammation in Crohn's disease (CD), ulcerative colitis, and celiac disease. 4 A defective intestinal barrier allows an increased transcellular and paracellular passage that leads to intestinal and systemic inflammation. 5 Accumulating evidence indicates that the immune system plays an important role in modulation of the intestinal barrier function. Immune cells including monocytes, macrophages, and dendritic cells have been shown to be involved in the disturbance of the barrier function. 6 In addition, tumor necrosis factor (TNF)-a, interferon (IFN)-g, and interleukin (IL)-1b are proinflammatory cytokines involved in intestinal barrier dysfunction. 7, 8 These inflammatory cytokines increase the paracellular route by upregulating the expression and activity of the epithelial myosin light chain kinase (MLCK). 7, 8 MLCK activation catalyzes the phosphorylation of the myosin light chain leading to contraction of Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.ibdjournal.org).
perijunctional actin-myosin filaments and opening of the TJ barrier. 9, 10 Inhibition of MLCK activity prevents increased intestinal TJ permeability. 11, 12 Besides its role in the regulation of the paracellular route, MLCK also modulates the transcellular passage of antigens and microbes. 13 MLCK plays a central role in the regulation of intestinal TJ permeability. 9, 14, 15 MLCK mediates an increase of intestinal permeability provoked by physiologic as well as pathogenic bacteria. 3, [16] [17] [18] In addition, MLCK expression and activity have been shown to be altered in CD. 19, 20 MLCK protein expression is increased in intestinal tissues of patients with CD and correlated with the degree of CD activity, suggesting that it may contribute to the inflammatory process. 19 CD is a multifactorial disease including environmental and genetics risk factors. Among the genetic components, mutations in the nucleotide oligomerization domain 2 (NOD2) gene, also known as caspase recruitment domain 15 (CARD15), were linked to an increased risk to develop CD. 21, 22 Approximately, 30% to 50% of patients with CD exhibit 1 or more genetic NOD2 variants, which are considered as loss of function mutations. 21, 22 NOD2 belongs to a family of receptors involved in innate immunity, and it is activated by muropeptides, which are components of the bacterial cell wall. 23 NOD2 is known to play a crucial role in the homeostasis of the intestinal mucosa not only by controlling the induction of immune responses but also by regulating the intestinal permeability in humans 24 and mice. 13, 25, 26 Alterations of the homeostasis of PP including Th1 cytokine secretion and increased permeability have been reported in mice deficient or mutated for Nod2 13, 25 as well as in patients with CD. 27, 28 Moreover, the earliest macroscopic lesions in CD, named aphtoid ulcerations, have been described as located at the center of isolated lymphoid follicles or PP. 29, 30 In mice, Nod2 deficiency or mutation has also been associated with increased bacterial translocation across the PP of the ileum, even in the absence of inflammatory lesions. 13, 25 This excessive bacterial translocation results from a microbiota-driven abnormal crosstalk between CD4 + T cells and epithelial MLCK. 13 Furthermore, transfer of wild-type (WT) bone marrow to Nod2-knockout (KO) mice normalizes the permeability, whereas transplantation of bone marrow from Nod2-KO mice to conventional mice increases epithelial permeability. 16, 31 However, the underlying mechanisms remain unknown.
In this study, we investigated the mechanisms by which hematopoietic Nod2 controls epithelial permeability as well as the impact of Nod2 activation in the nonhematopoietic compartment on intestinal barrier function.
METHODS

Mice
C57BL/6 WT and Nod2-KO were generated in the animal facility of Robert Debré Hospital. 25 All mice were housed under specific pathogen-free conditions and were monitored every 6 months in accordance with the full set of FELASA high standard recommendations. Housing and experiments were conducted according to institutional animal health care guidelines and were approved by the local ethical committee for animal experimentation (Comité Régional d'Ethique en matière d'Expérimentation Animale no. 4, Paris, France).
Generation of Chimeric Mice
Five million bone marrow stem cells were isolated from WT Ly5.1 (CD45.1 haplotype) or Nod2-KO Ly5.2 (CD45.2 haplotype) mice and intravenously injected into lethally irradiated WT Ly5.1 or Nod2-KO Ly.5.2 recipients. 17 Three months after transfer, chimerism was assessed by flow cytometry using antibodies for Ly5.1 and Ly5.2. At least 85% and 90% of immune cells from PP and spleen (see Supplementary Fig. S1 , Supplemental Digital Content 1, http://links.lww.com/IBD/B505), respectively, were graft derived as previously described. 16 
Ussing Chamber (UC) Experiments
Biopsies from PP and regular ileal mucosa (without PP) were mounted in the UC exposing 0.196 cm 2 of tissue surface to 1.5 mL of circulating oxygenated Ringer solution at 378C. Paracellular permeability was assessed by measuring the mucosal-to-serosal flux of 4 kDa fluorescein isothiocyanate (FITC)-dextran (Sigma, St Quentin Fallavier, France). 25 To investigate the effect of Nod2 stimulation, mice were pretreated by intraperitoneal (i.p.) injection of MDP (100 mg per mice$per day; Sigma) for 2 consecutive days before experimentation and 10 mg/mL of MDP was added to the luminal side of the UC. 13 For MLCK inhibition, mice were pretreated by ML-7, and 20 mg/mL of ML-7 was added to the UC. 13 Depletion of CD4 + T Cells and Inhibition of IFN-g and MLCK CD4 + T cells were depleted by 2 i.p. injections of 100 mg of purified anti-CD4 (GK1.5; Pharmingen, Heidelberg, Germany), 96 and 24 hours before experimentation. 13 IFN-g depletion was obtained by i.p. injections of 200 mg of anti-IFNg (XMG1.2; BD Biosciences, Heidelberg, Germany) 24 hours before experimentation. 13 MLCK inhibition was obtained by i.p. injection of ML-7 (2 mg/kg, Sigma) twice daily during 4 days before killing. 13 To investigate the effect of Nod2 stimulation, adult mice were i.p. pretreated with MDP (100 mg$mice 21 $d 21 ; Sigma) for 2 consecutive days before experimentation, and 10 mg/mL of MDP was added to the luminal side of the UC. 13 
Expression Vectors and Transfections
All cloning experiments were performed using the Gateway system (Invitrogen, vVllebon sur Ivette, France). cDNAs were cloned into pDONR/Zeo from polymerase chain reaction (PCR) products. All cDNAs (NOD2 WT and NOD2 3020insC ) were fully sequenced in pDONR and subsequently shuttled into pEGFP-GW as described in reference 32. Caco-2 cell transfections were performed using Lipofectamine 2000 (Invitrogen). Three cycles of selection were performed by addition of G418 (Sigma, 400-800 mg/mL, 4 d/cycle of selection) to the culture medium. After the last cycle, most efficiently transfected Caco-2/TC7 cells were selected by sorting the most GFP-positive cells. After transfection with NOD2 cDNA, the high levels of NOD2 expression did not alter cellular growth and differentiation as evidenced by the measurement of mRNA levels for sucrase-isomaltase and alkaline phosphatase as well as alkaline phosphatase activity (see Supplementary Fig. S2 , Supplemental Digital Content 1, http://links.lww.com/IBD/B505). Similarly, mRNA expression of MLCK, Occludin, and Zo-1 were not modified by NOD2 transfection (see Supplementary Fig. S2 , Supplemental Digital Content 1, http://links.lww.com/IBD/B505).
Cell Line Models
Caco-2 cells were purchased from "Deutsche Sammlung von Mikroorganismen und Zellkulturen" (DSMZ). Caco-2/TC-7 was kindly provided by Dr Monique Rousset (University of Paris VI, France). Caco-2 and Caco-2/TC-7 cells were grown in Glutamax Dulbecco's modified Eagle's medium (Gibco, France) supplemented with 20% of heat inactivated fetal bovine serum (Biowest, Nuaillé, France), 1% nonessential amino acids and antibiotics (100 U/mL penicillin, 100 mg/mL streptomycin) at 378C in a watersaturated and 5% CO 2 -containing atmosphere. 17 Cells were seeded in Transwell inserts (Costar, Illkirch, France) and grown for 14 days. To measure paracellular permeability, FITC-4kD dextran (10 25 M) was added into the apical compartment of the transwell chamber, and the paracellular permeability was monitored for 24 hours by sampling 400 mL from the basolateral compartment. 17 For coculture experiments, Caco-2 cells were seeded in Transwell inserts for 10 days and then cultivated with freshly isolated PP cells. Isolated cells were analyzed by flow cytometry on a FACScalibur (Becton Dickinson, Pont de Claix, France) with Cell Quest 3.3 (Becton Dickinson). Monoclonal antibodies for staining of cell suspensions were purchased from BD Biosciences: anti-CD3, anti-CD4, anti-CD8, anti-CD11c, anti-CD45R/B220, and antiAnnexin V. Anti-Caspase 3 was purchased from eBioscience (San Diego, CA) (see Supplementary Fig. S3 , Supplemental Digital Content 1, http://links.lww.com/IBD/B505). The proportions of B, T, and dendritic cells were 65%, 30%, and 5%, respectively. Among the T-cell populations, the proportion of CD4 + cells was 40% for WT mice and 60% for KO mice. Approximately 27% of cells were positive for CD8 in both mouse strains (see Supplementary Fig. S3 , Supplemental Digital Content 1, http://links.lww.com/IBD/B505). Immune cells (10 6 ) were added to the basolateral chamber of the Caco-2 cells and the cultures were maintained for 1 to 7 days. The lymphocytes survived in culture for up to 7 days as indicated by the presence of few apoptotic cells after culture (see Supplementary Fig.  S3 , Supplemental Digital Content 1, http://links.lww.com/IBD/B505). After 7 days of coculture, supernatants were removed and the productions of IL-1b, IL-4, IL-6, IL-12, IFN-g, and TNF-a were determined by ELISA (BD Biosciences).
Ability of CD4 + T Cells to Synthetize IFN-g and TNF-a
Freshly isolated cells from PP of WT and KO mice were stimulated or not with anti-CD3 and anti-CD28 and incubated at 378C and 5% CO 2 for 4 hours. After stimulation, cells were washed with phosphate-buffered saline containing 0.1% BSA and incubated with the monoclonal antibodies for surface markers (CD3/CD4/CD8, BD Biosciences) at 48C in the dark for 30 minutes. After 2 washing steps, the cells were fixed and permeabilized with Cytofix/Cytoperm solution and stained for intracellular IFN-g and TNF-a with antibodies from BD Biosciences. Flow cytometry was performed using a BD FACSCalibur flow cytometer, and data were analyzed using Cell Quest 3.3 (Becton Dickinson).
RNA Extraction and Quantitative Real-Time PCR
After extraction with the NucleoSpin RNA II Kit (Macherey-Nagel, Hoerdt, France), total RNAs were converted to cDNA using random hexanucleotides and then used for RT-PCR (Invitrogen). For more details see reference 33. We performed qPCR with the QuantiTect SYBR Green PCR Kit (Applied, Courtaboeuf, France) using sense and antisense primers specific for G3pdh, the long Mlck isoform (specifically expressed by epithelial cells), Nod2, Mlck, Tnf-r1, and Tnf-r2. The cycle threshold (Ct) was defined as the cycle number at which the normalized fluorescent intensity passed the level of 10 times the standard deviations of the baseline emission calculated on the first 10 PCR cycles. Results are expressed as 2 2DDCt .
Protein Analysis
MLCK concentrations were determined, as previously described by ELISA according to the manufacturer recommendations (Cusabio, Baltimore, MD). 17 Interfering RNA experiments were done with ON-TARGET plus SMARTpool siRNAs targeting Tnf-r1 and Tnf-r2 and a nontargeted control siRNA (Dharmacon, Lafayette, France). Transfections were done 48 hours before experiments according to the manufacturer's instructions (Invitrogen). Caco-2 cell transfections were performed using Lipofectamine 2000 (Invitrogen) as previously described. 17 Monitoring of P-65 and C-jun nuclear translocation was performed with TransAm NF-kB and C-jun Kits. After treatment, nuclear proteins from Caco-2 cells were removed and the levels of nuclear p65 NF-kB or C-jun subunits were assessed according to the manufacturer's instructions (Active motif, La Hulpe, France).
Statistical Analysis
For all the analyses, multigroup comparisons were performed by applying 1-way ANOVA statistics with Bonferroni correction for multiple comparisons and an unpaired t test assuming Gaussian distribution. The Gaussian distribution was tested by the Kolmogorov-Smirnov test. Statistical analysis was performed using GraphPad Prism 5.00 (GraphPad Software). A 2-sided P value , 0.05 was considered as statistically significant.
RESULTS
Nod2 deficiency in hematopoietic cells increases gut epithelial permeability by MLCK-dependent mechanisms.
It is well established that Nod2 KO mice are characterized by increased paracellular and transcellular permeability across PPs. 13, 25, 33, 34 An epithelial barrier defect, characterized by an elevated rate of bacterial translocation, is related to higher level of CD4 + T cells in Nod2 KO mice. 25 Likewise, we have recently shown that transplantation of bone marrow stem cells from Nod2 KO to irradiated WT (KO/WT) mice increased paracellular permeability in PP and ileum to levels comparable to those in KO/KO mice. 16, 31 Reciprocally, in comparison to KO/KO mice, KO mice transplanted with Nod2 wt bone marrow stem cells (WT/KO) had decreased paracellular permeability in PP and ileum levels, comparable to those in WT/WT transplants. 16 Taken together, these results evidenced that Nod2 deficiency in the hematopoietic compartment increased the paracellular permeability, whereas its defect in the nonhematopoietic compartment was unable to alter the permeability (see Table S3 , Supplemental Digital Content 1, http://links.lww.com/IBD/B505). However, the mechanism by which hematopoietic Nod2 deficiency altered epithelial permeability remained unclear. In our new experiments, we show that higher levels of permeability in PP and ileum (without FIGURE 1. Nod2 deficiency in the hematopoietic compartment alters gut epithelial barrier function by MLCK-dependent mechanisms. A, Paracellular permeability of PP and ileal mucosa were investigated in chimeric mice transplanted with hematopoietic cells from either WT or Nod2 KO mice in basal conditions or after MLCK inhibition by ML-7. B, Protein expression of inflammatory cytokines was investigated in the indicated locations of chimeric mice in basal conditions or after MLCK inhibition by ML-7. C, mRNA expression of Tnf-r2, Tnf-r1, Mlck, and Zo-2 were assessed in basal conditions by real-time PCR. Each point represents 1 mouse; mean 6 s.e.m. Statistical differences between groups are indicated on the graphs. *P , 0.05; **P , 0.01; ***P , 0.001. PP) from chimeric mice with defective Nod2 in their hematopoietic compartment (Fig. 1A) are associated with increased expression of inflammatory cytokines such as TNF-a, IFN-g, and IL-12 ( Fig. 1B) and of TNF receptor 2 (Tnf-r2) but not Tnf-r1 (Fig.  1C) . 31 As expected from experiments previously performed in Nod2 KO mice, 13 Mlck mRNA expression was also increased in chimeric KO/KO mice (Fig. 1C) . Overexpression of Mlck is related to deficiency of Nod2 in the hematopoietic lineage, because chimeric KO/WT and KO/KO mice have comparable Mlck mRNA expression. In addition, mRNA expression of zonula occludens 2 (Zo-2), that was shown to be important for the maintenance of MLCK-controlled TJs, was decreased in PP and ileum of KO/WT as well as in KO/KO chimeric mice (Fig. 1C) . Inhibition of MLCK activity by ML-7 restored paracellular permeability and cytokine production in KO/WT and KO/KO chimeric mice to levels comparable to the WT/WT mice (Fig. 1A, B) . Thus, increased paracellular permeability and cytokine production in mice deficient for hematopoietic Nod2 is dependent on MLCK activity. These data evidenced that the higher level of paracellular permeability linked to Nod2 deficiency in the hematopoietic compartment is associated with increased IFN-g and TNF-a levels and dependent of the MLCK expression and activity. Moreover, the fact that restoration of a normal paracellular by ML-7 treatment is also associated to normalization of the expression of proinflammatory cytokines, in both KO/WT and KO/KO chimeric mice shows that Nod2 deficiency in the hematopoietic compartment induced an abnormal environment triggering immune cell malfunctioning.
As CD4 + T cells are more abundant in PP from Nod2 KO mice, 13, 25, 31, 33 we have checked the role of CD4 + T cells in the altered paracellular permeability, their capacity to produce IFN-g and TNF-a and the involvement of these cytokines in the alteration of the paracellular permeability. Depletion of CD4 + T cells restored paracellular permeability in PP and ileum of Nod2 KO mice and reduced both IFN-g and TNF-a production ( Fig. 2A-C and see Supplementary Fig. S4 , Supplemental Digital Content 1, http://links.lww.com/IBD/B505), and bacterial translocation (previously published results) 13 CD4 + T-cell depletion also normalized the mRNA levels of a set of genes known to modulate paracellular permeability in PP (see Table S1 , Supplemental Digital Content 1, http://links.lww.com/IBD/B505) and ileal mucosa (see Table S2 To confirm the in vivo results concerning the role of hematopoietic Nod2, we cultivated Caco-2 cells in transwell inserts with PP-derived immune cells from Nod2 KO or WT mice added in the baolateral compartment. Culture in the presence of Nod2 KO PP immune cells resulted in increased paracellular permeability of Caco-2 monolayers when compared with culture with WT PP cells (Fig. 3A) . ELISA analysis was performed on supernatant obtained from the basolateral chamber of the transwell system to monitor the secretion of cytokines by immune cells of PP from KO and WT mice for Nod2. In cultures with PP cells from Nod2 KO , mice the production of IFN-g and TNF-a, but not of IL-1b or IL-6 were significantly raised in comparison to culture with WT PP cells (Fig. 3B) . By contrast, no secretion of IL-4, IL-8, or IL-12 was detected in the cell supernatant (data not shown). These data also suggested the fact that Nod2 deficiency in the hematopoietic compartment induced an intrinsic defect in immune cells from PP, because increased levels of IFN-g and TNF-a were spontaneously released by immune cells of PP from Nod2 KO mice in the basolateral chamber of transwell system. To mimic the impact of these cytokines on the intestinal epithelium, Caco-2 monolayers were exposed to human IFN-g and/or TNF-a (Fig. 3C-F) . As previously shown, 8, 35 exposure to these cytokines increased paracellular permeability (Fig. 3C) , MLCK protein level (Fig. 3D) , and Nod2 and Tnf-r2 mRNA expression but not Tnf-r1 (Fig. 3E) . Using RNA silencing experiments, we also confirmed that Mlck overexpression was dependent on TNF-R2 (Fig. 3F) . By contrast, exposure to IFN-g and TNF-a strongly increased mRNA expression of NOD2 through the TNF-R1 receptor (Fig. 3G) . In vivo, Nod2 overexpression is also found in the ileum from KO/WT chimeric mice but not in WT/KO chimeric mice (Fig. 3H) . Taken together these data evidenced that CD4 + T cells secreting IFN-g and TNF-a increase Nod2 expression in epithelial cells through a TNF-R1-dependent mechanism. Moreover, Nod2 deficiency in the hematopoietic compartment induced not only an abnormal environment triggering T-cell malfunctioning but also an intrinsic defect in CD4 + T cells overexpressing IFN-g and TNF-a.
Nod2 stimulation in the nonhematopoietic compartment normalizes gut barrier function through TAK1/RIP2 and MAP Kinase signaling pathways.
Knowing that Nod2 in the hematopoietic cells is required to regulate gut barrier function, 13,31,33 we next investigated if Nod2 overexpression in the epithelial cells induced by CD4 + T cells from PP of Nod2 KO mice could modulate the paracellular permeability. In contrast to KO/KO chimeras, exposure of chimeric mice expressing Nod2 only in the nonhematopoietic compartment (KO/WT) to MDP normalized paracellular permeability in PP and ileum (Fig. 4A and Table S3 , Supplemental Digital Content 1, http://links.lww.com/IBD/B505). The restoration of paracellular permeability was associated with a normalization of proinflammatory cytokine production ( Fig. 4B and Table S3 , Supplemental Digital Content 1, http://links.lww.com/IBD/B505), of Mlck and Zo-2 mRNA expression but not of Tnf-r1 and Tnf-r2 mRNA expression (Fig. 4C) . Thus, activation of Nod2 in nonhematopoietic cells is able to suppress the elevated paracellular permeability induced by excessive IFN-g and TNF-a secretion by Nod2-deficient CD4 + T cells. Moreover, because the normalization of the paracellular permeability by MDP is also able to restore a normal secretion of IFN-g and TNF-a by CD4 + T cells, Nod2 deficiency in the hematopoietic compartment induced an abnormal environment triggering T-cell malfunctioning.
To investigate the underlying mechanisms by which Nod2 controls the paracellular permeability in epithelial cells, we exposed Caco-2 cells pretreated with IFN-g and TNF-a to MDP. In line with the in vivo results, MDP abrogated the effect of proinflammatory cytokines on the increase of paracellular permeability (Fig. 5A ) and on the MLCK protein level (Fig. 5B) as well as mRNA expression (Fig. 5C ) in Caco-2 monolayers. The induction of NOD2 or Tnf-r2 overexpression triggered by proinflammatory cytokines was not influenced by MDP treatment (Fig. 5C ).
When exposed to MDP, NOD2 recruits TAK1 and RICK proteins which then modulate MAP kinase 36 and NF-kB pathways. 37 To delineate the signaling mechanisms downstream of NOD2 and controlling MLCK expression, Caco-2 monolayers were treated with TAK1 (5Z-7-Oxozeanol) or RICK (PP2) FIGURE 2. CD4+ T cells and IFN-g trigger epithelial permeability dysfunction in Nod2 KO mice. Paracellular permeability (A) and levels of cytokines (IFN-g (B) and TNF-a (C)) in PP and ileal mucosa were monitored under basal conditions and after depletion of CD4 + cells. Analysis was performed in WT and Nod2 KO mice by measurement of the flux of FITC-dextran 4 kDa (FD4) using an Ussing chamber or by ELISA, respectively. D, Cells from PP of WT and Nod2 KO mice were cultured with or without anti-CD3 and anti-CD28 for 4 hours. After surface (CD4/CD8) and intracellular (IFN-g or TNF-a) staining, cells were gated as CD3 + CD4 + and the percentage of cells positive for IFN-g and TNF-a were determined using Cell Quest 3.3 software. Paracellular permeability (E) and level of IFN-g (F) in PP and ileal mucosa were monitored under basal conditions and after neutralization of IFN-g. Analysis was performed in WT and Nod2 KO mice by measurement of the FD4 flux in an Ussing chamber or by ELISA, respectively. Each point represents 1 mouse; at least 3 independent experiments; mean 6 s.e.m. Statistical differences between groups are indicated on the graphs (*P , 0.05; **P , 0.01 and ***P , 0.001 versus control group).
inhibitors. Both treatments suppressed the protective effect of MDP on PP permeability (Fig. 5D) . A comparable inhibition was observed with inhibitors of MEK1 (PD98059), JNK (JNK inhibitor II; SP600125), or P-38 (SB202190) (Fig. 5E) . Moreover, MDP treatment triggered nuclear translocation of c-Jun (Fig. 5F ). By contrast, MDP treatment abrogated the nuclear translocation of p-65 (a subunit of the NF-kB complex) induced by IFN-g and TNF-a 38 and previously shown to increase MLCK expression induced by IL-1b 7 (Fig. 5G) . As expected, the suppressive effect of MDP on nuclear translocation of p-65 was abolished by TAK1 or RICK inhibition (Fig. 5G) . As a whole, this set of data indicated that Nod2 activation controlled PP permeability by the recruitment of the TAK1/RICK complex and the regulation of MAP kinase and NF-kB pathways leading to MLCK activation.
Mutated epithelial NOD2 fails to protect the epithelial barrier in response to IFN-g and TNF-a.
Because epithelial NOD2 stimulation by MDP was able to reverse the barrier dysfunction in the presence of proinflammatory cytokines, we paid special attention to CD-associated mutations. NOD2 3020insC is a genetic variant encoding for a truncated protein (1007fs) associated with ileal CD and barrier defect. To analyze its function, Caco-2/TC7 cells were stably transfected with either an empty control vector or a vector containing NOD2 WT or NO-D2 3020insC cDNA. After transfection, NOD2 WT and NOD2 3020insC Caco-2/TC-7 cells exhibited a 1.000-fold increase of NOD2 mRNA levels when compared with the control (see Supplementary 5 ng/mL) and/or TNF-a (5 ng/mL). Where indicated, Caco-2 cells were treated with ML-7 (20 mg/mL). D, MLCK protein expression and (E) NOD2, Tnf-r1, and Tnf-r2 mRNA expression in Caco-2 cells cultured with or without IFN-g and/or TNF-a was assessed by ELISA or real-time PCR, respectively. MLCK mRNA (F) and (G) NOD2 mRNA expression was monitored in Caco-2 cells transfected with siRNA directed against TNF-R1 or TNF-R2 or control si-RNA (Si-Neg). At least n ¼ 12 wells per group; 3 independent experiments; mean 6 s.e.m. Statistical differences between groups are indicated on the graphs. H, Nod2 mRNA expression in intestinal mucosa was monitored in chimeric mice expressing Nod2 in hematopoietic and/or nonhematopoietic compartments. Each point represents 1 mouse; Statistical differences between groups are indicated on the graphs (*P , 0.05; **P , 0.01 and ***P , 0.001 versus control group).
permeability in control cells expressing low levels of NOD2 while it had a strong effect on cells overexpressing NOD2 WT but not those containing the NOD2 3020insC construct (Fig. 6A) . As expected, MLCK protein levels were correlated with the grade of paracellular permeability (Fig. 6B) . We thus concluded that epithelial NOD2 3020insC mutation was resulting in loss of homeostatic epithelial barrier integrity.
DISCUSSION
NOD2 mutations are associated with CD pathogenesis which is characterized by epithelial permeability dysfunction. In mice, Nod2 deficiency increases paracellular permeability 25, 34 and bacterial translocation across PP, 13 highlighting its role in the regulation of gut barrier function. Here, we highlighted the underlying mechanisms notably using experiments in reciprocal bone marrow chimeras from WT and Nod2 KO mice, the results of which are summarized in the Supplementary Table S3 previously been shown to control transcellular permeability and bacterial translocation across PP in Nod2 KO mice. 13 The defective intestinal barrier is manifested by an increase in not only transcellular permeability but also paracellular passage, which leads to intestinal and systemic inflammation. Here, we have shown that Nod2 deficiency increases paracellular permeability in PP and the ileal mucosa by mechanisms that are dependent on CD4 + T cells and MLCK activity. Having previously shown in bone marrow chimeras that Nod2 deletion in the hematopoietic compartment leads to higher paracellular permeability, 16, 31 in this new study, we demonstrated the importance of Nod2 expression in CD4 + T cells for the control of paracellular intestinal permeability. In accordance with our studies, it has been shown that Nod2 deficiency in the hematopoietic lineage led to exacerbation of 2,4,6-Trinitrobenzenesulfonic acid-induced colitis. 39 Likewise, we show that transfer of Nod2-deficient bone marrow to conventional mice increases paracellular permeability through MLCK-activation triggered by proinflammatory cytokines. In addition, the higher level of paracellular permeability and MLCK overexpression in Nod2 KO mice was abrogated after transfer of Nod2-expressing bone marrow. Together, these data support the concept of bone marrow transplantation as a potential therapeutic approach to restore intestinal homeostasis of patients with CD with deleterious NOD2 mutations.
Nod2 deficiency in the immune system leads to an increased secretion of IFN-g and TNF-a by CD4 + T cells and upregulation of MLCK expression and activity through TNF-R2 induction as previously reported. 35 Our results are in agreement with previous works showing that IFN-g and TNF-a act in synergy to induce disruption of the epithelial barrier. 8, 35, 38, 40, 41 IFN-g enhances the expression level of Tnf-r2, allowing TNF-a to increase the expression and activity of MLCK ultimately resulting in modulation of the TJ architecture. 8, 42 This increase of MLCK expression is driven by upregulation of the TNF-R2. IFN-g and TNF-a acting on human epithelial cell lines have been described to increase the Nod2 expression. 43 We confirmed that stimulation FIGURE 5 . MDP stimulation of epithelial cells abrogates the increased permeability driven by IFN-g and TNF-a stimulation via a Nod2/RICK/Tak1/ MAPK pathway. Caco-2 cells were stimulated or not with IFN-g (2.5 ng/mL) and/or TNF-a (5 ng/mL). Where indicated, polarized Caco-2 monolayers were treated with MDP (20 mg/mL), Tak1 inhibitor (5Z-7-Oxozeanol, 10 mg/mL), RICK inhibitor (PP2, 10 mg/mL), P-38 inhibitor (SB203580, 10 mg/mL), JNK Inhibitor (SP600125, 10 mg/mL), or MEK1 Inhibitor (PD98059, 10 mg/mL). A, D. and E, Paracellular permeability was investigated by measurement of FITC-dextran accumulation in the basolateral compartment of the Transwell after 24 hours. B, MLCK protein level was assessed by ELISA. C, Mlck, NOD2, Tnf-r1, and Tnf-r2 mRNA expression was determined by real-time PCR. F and G, Nuclear protein levels of p-65 and c-Jun. At least n ¼ 12 wells per group; 3 independent experiments; mean 6 s.e.m. Statistical differences between groups are indicated on the graphs.
of Caco-2 cells with IFN-g and TNF-a strongly increases NOD2 mRNA expression and showed that NOD2 overexpression is mediated by Tnf-r1 but not Tnf-r2. Thus, our better understanding of how hematopoietic Nod2 expression impacts epithelial barrier function opens new pathways for therapeutic strategies to treat patients with CD.
Inside the ileal mucosa, Nod2 is expressed in the hematopoietic and nonhematopoietic compartment. Although Nod2 deficiency in the hematopoietic lineage is the "primum movens" stimulus altering the paracellular permeability, we show that Nod2 expression in nonhematopoietic cells can regulate epithelial barrier function after exposure to bacterial peptidoglycan-derived MDP. Nod2 stimulation with MDP induces recruitment and association of the RICK/TAK1 complex with Nod2. 18 Accordingly, we show that pharmacological inhibition of RICK or TAK1 abrogates the protective role of Nod2 against the destabilization of epithelial homeostasis induced by IFN-g and TNFa. It was previously shown that Nod2 stimulation by MDP is able to activate MAP kinases. 36, 44 In agreement with these findings, we have shown that Nod2 stimulation induces activation of MAP kinases, indicated by excessive nuclear translocation of C-jun and that the pharmacological inhibition of MAP kinases suppressed the protective role of Nod2.
Specific overexpression of MLCK in the epithelial cell is known to be insufficient to cause experimental intestinal disease but can broadly activate mucosal immune responses and accelerate the onset and severity of immune-mediated colitis. 5 In agreement, we have shown that Nod2 deficiency in the hematopoietic compartment increased the expression and activity of the MLCK in the epithelial cells (elevated the paracellular permeability) then enhanced the secretion of proinflammatory cytokines (IFN-g, IL-12 and TNF-a) by immune cells. Similarly, by blocking the MLCK activity with ML-7, the paracellular permeability as well as the secretion of proinflammatory cytokines (IFN-g, IL-12 and TNF-a) by immune cells were normalized and similar to the chimeric mice expressing Nod2 in both hematopoietic and nonhematopoietic compartment. These results evidenced that Nod2 deficiency in the hematopoietic compartment induced an abnormal environment triggering T-cell malfunctioning.
In humans and mice, Nod2 has been described to play an important role in the regulation of both innate and adaptive immune responses. Thus, NOD2 ligand (MDP) is known to activate NF-kB pathway in human CD4 + T cells and to protect these CD4 + T cells from death receptor Fas-mediated apoptosis. 45 Importantly, defective apoptosis protection in T cells isolated from a patient with the disease-associated polymorphism (NOD2 1007fs ) has been reported. 45 In agreement, we have evidenced that Nod2 deficiency in the hematopoietic compartment induced an intrinsic defect in CD4 + T cells oversecreting IFN-g and TNF-a.
Together these data demonstrate, for the first time, an interplay between hematopoietic and nonhematopoietic cells maintaining homeostasis of the intestinal epithelial barrier in a Nod2-dependent fashion. FIGURE 6 . The 3020insC Nod2 mutation is associated with a defective barrier function in response to in vitro MDP stimulation. A, Paracellular permeability and (B) MLCK protein expression were measured in Caco-2/TC7 cells stably transfected with NOD2 WT or NOD2 3020insC cDNA, or with a control vector after stimulation with IFN-g and/or TNF-a. Caco-2/TC-7 cells were treated with MDP as indicated. At least n ¼ 9 wells per group; 3 independent experiments; mean 6 s.e.m; *P , 0.05; **P , 0.01 and ***P , 0.001 versus indicated group.
